Guangdong Taiantang Pharmaceutical Co.Ltd(002433) : Guangdong Taiantang Pharmaceutical Co.Ltd(002433) announcement of the resolution of the 21st Meeting of the Fifth Board of supervisors

Stock Code: 002433 stock abbreviation: Guangdong Taiantang Pharmaceutical Co.Ltd(002433) Announcement No.: 2022-016 Guangdong Taiantang Pharmaceutical Co.Ltd(002433)

Announcement of resolutions of the 21st Meeting of the 5th board of supervisors

The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

1、 Meetings held

The 21st Meeting of the 5th board of supervisors of Guangdong Taiantang Pharmaceutical Co.Ltd(002433) (hereinafter referred to as “the company”) was held in the conference room on the second floor of Qilin park on February 18, 2022 by combining on-site voting and communication voting. The notice of the meeting was sent by e-mail, fax, delivery and telephone on February 8, 2022. There are 3 supervisors who should attend the meeting and 3 supervisors who actually attend the meeting, which is in line with the quorum for convening the meeting of the board of supervisors. The meeting was presided over by Mr. Chen Yinsong, chairman of the board of supervisors. The convening, convening and voting procedures of this meeting comply with the provisions of the company law, the articles of association, the rules of procedure of the board of supervisors and other relevant laws, administrative regulations, departmental rules and normative documents, and the meeting is legal and effective.

2、 Deliberations of the meeting

(I) deliberated and passed the proposal on providing guarantee for the payment of kangaido

After review, the board of supervisors believes that after the termination of the sale of major assets of the company, kangaido will become the holding subsidiary of the company. This guarantee is conducive to the normal business operation of kangaido. The board of supervisors believes that the risk of providing guarantee for kangaido suppliers is controllable and there is no damage to the interests of the company and shareholders, especially small and medium-sized shareholders. Therefore, we agree to this guarantee and submit it to the general meeting of shareholders of the company for deliberation.

Voting results: 3 in favor, 0 against and 0 abstention.

3、 Documents for future reference

Guangdong Taiantang Pharmaceutical Co.Ltd(002433) resolution of the 21st Meeting of the 5th board of supervisors

It is hereby announced

Guangdong Taiantang Pharmaceutical Co.Ltd(002433) board of supervisors February 19, 2002

- Advertisment -